Background: More than half of traditional medicines are of natural origin and research has shown that these are associated with fewer side effects than the synthetic ones, since less than 10% of the 350,000 identified plant species have been exposed to some amount of bioactive screens, it is now the aim of researchers to screen more plants and also identify the active ingredients responsible for detected bioactivities. These we believe may provide the foundation for identifying new drug leads that may prove useful against chronic lifestyle diseases. This review takes a look at the work that has currently been conducted on Tillandsia recurvata commonly known as ball moss which is believed to assist with future research.
INTRODUCTION

15
Even though recent developments have been made over the last decade in the 16 advancement of new drugs vis-a-vis genetics, biotechnology and genomics, still, natural 17 products remain vital to the New Era. There has been a recent and renewed interest in the 18 advantageous properties of natural products for the treatment and prevention of chronic 19
diseases. An approximated 80% of the world's population depend primarily on natural plant 20 products which are either sold as herbs, food supplements or drugs [1] . Of the top 50 drugs 21 sold in European pharmacies, statistics show that roughly 50% of these are based on or are 22 derivatives of natural products [1] . 23 24 It is then not surprising when the statement is made that much of the wealth of a country 25 resides in its plant inheritance, whether the plants are endemic, naturalized or recent 26
introductions [2] . And even with that knowledge only about 10% of the existing 350,000 27 plant species known worldwide have been screened for biological activity [3] . Of these, 28
Jamaica accumulates roughly 2888 with approximately 30% endemism [4] . Jamaica is 29 known for its profound reliance on the usage of herbal plants to treat illnesses as evidenced 30 in a report by the Tropical Metabolism Research Unit (TMRU) of the UWI, Jamaica, where 31 71% of patients reported using herbal remedies before seeing the doctor [5] . This is 32
however becoming an increased concern as more and more information is revealed about 33 drug interactions. It would be nonetheless a safe assumption to make that if adverse events 34 and interactions amongst herbs, drugs or both are of concern, then it would be blatantly 35 visible given the copious usage of these products. On the other hand, pharmacokinetic and 36 pharmacodynamics data is lacking for many botanical and nutritional supplements. The 37
adverse event reporting systems that are presently in place for drugs are inadequate for 38 monitoring dietary supplement products given the vast number of complex and unique 39 formulations [6] . As a result acquiring a better understanding of traditional medicine, 40 evaluating its phytochemical constituents, its impact on drug metabolising enzymes and 41 ultimately its incorporation in modern medical practise has been the preferred and safer 42 route to ensuring the health and well-being of all individuals [2, 7-9] 43 44
This review explores the bioactivity of the ball moss plant, a plant that is currently being 45 researched by our laboratory. Since the introduction of in vitro high-throughput screening 46 protocols, laboratories are now able to access a wide array of bioactive screens even though 47 it isn't always feasible to define and choose the appropriate target for any given disease [3] . 48
Because of this, our laboratory has conducted varying bioactive screens and published 49 several manuscripts, nonetheless, it helps to have access to as much of the bioactivity data 50 in one paper as it can provide insight into the direction to be taken to expedite the production 51 of new drug leads. 52 53
Tillandsia recurvata L. a flowering plant of the pineapple family Bromeliaceae, commonly 54 called the Jamaican Ball Moss (Figure 1 The plant is characterized by the presence of a rudimentary root system and shoots having 80 5-8 linear leaves forming a rosette, covered with peltate, absorptive trichomes [11] . It forms 81 a tangled mass of leaves and aerial roots, which are dry and grey colored and turns green 82 when exposed to moisture. Older plants develop multiple ramets which form a spherical 83 tussock ranging in size from a golf ball up to the size of a basketball, hence the common 84 name "ball moss" [11, 12] . Due to its abundance and wide distribution through the island, 85
our scientists decided to investigate the bioactive worth of the ball moss plant 86 87 88 Figure 1 In searching for natural lead molecules that possess effectiveness against selected cancers, 158
it is important that one has a fair idea of the processes involved in tumour growth as this will 159 guide researchers into the appropriate bioactive screens to execute which will offer insight 160
into the effectiveness of the tested entity. It is then understood that whilst finding molecular 161 entities that are cytotoxic towards cancer cells is favourable, it cannot be enough. Benign 162 tumours are those that are confined to one area and as such are not considered cancerous 163 as they do not pose a threat to the individual. However, when the tumour begins to 164 metastasize, that is, it begins spread and invades neighbouring tissues; it is considered 165 cancerous as its threat to the individual is exponentially augmented with every incremental 166 increase. One contributing factor towards the increase in tumour growth is the process of 167 angiogenesis, which is the physiological growth of new blood vessels from pre-existing ones. 168
This provides an ideal environment for the tumour as it is fed with the appropriate nutrients 169 so facilitating its growth. Tumours starved of angiogenesis will remain benign for an 170 indefinite period while those exposed experience a rapid exponential growth [40, 41] . It is 171 therefore prudent to investigate molecular entities that are not just able to reduce cancer cell 172 viability but also angiogenesis as well. Results from our lab showed that the crude 173 chloroform ball moss extract was not just cytotoxic against human cancer cell lines but it also 174 reduced angiogenesis as well [30] which means that it tackles the phenomenon of cancer 175 from not just one but two angles so making this plant an even more promising screening 176 agent against cancer. 177 178
Normal cellular growth is tightly regulated and various checkpoint systems are in place to 179 ensure the transition of healthy cells from one point in the cell cycle to the next. These 180 checkpoint systems such as cyclin dependent kinases are equipped to identify genomic 181 alterations within the cell and initiate fixing this before the cell is allowed multiply [42, 43] . In 182 the event the identified problem cannot be fixed the cell can induce cell death or apoptosis. 183
Cancer initiation can be caused when the checkpoint systems themselves are not 184 functioning as they should, be it via the process of carcinogenesis or hereditary. When this 185 occurs, there is no mechanism in place to initiate problem solving or apoptosis. It has 186 therefore become a recent and therapeutically germane direction to identify molecular 187 entities, be them inducers or inhibitors that can regulate particular kinases in hopes of 188 restoring the normal balance to cell proliferation [44] . This is believed to provide a solution 189
to uncontrollable growth evidenced in malignant tumours. Of the four hundred and fifty one 190 kinases investigated in our lab, the ball moss selectively inhibited 5 (CSNK2A2, MEK5, GAK, 191 FLT and DRAK1) and obtained Kd 50 s were below 20 µg/ml [29] . Since MEK5 and GAK 192 kinases have been associated with aggressive prostate cancer, the inhibitory properties of 193 the ball moss against them coupled with its previously found bioactivity towards PC-3 cell 194 line and its ability to reduce angiogenesis makes it even more promising in the arena of drug 195 discover towards prostate cancer amongst others. Due to these promising data, a 196 nutraceutical was developed by our lab known as the Alpha Prostate Formula 1. This 197 product we believe will promote the health of men's prostate in addition to providing 198 protection against prostate cancer. 199 200
2.4
Anti-Diabetic potential prolonged inflammation, and it is hypothesized that this could be enabled by a pathway that 210 involves a cytokine-mediated acute-phase response inflammatory process [49, 50]. C-211 reactive protein (CRP) is an acute-phase reactant produced under the stimulation of 212 adipocyte-derived pro-inflammatory cytokines, such as IL-6 and TNF-α making it an ideal 213 marker for the subclinical inflamm0ation [51] . Results from our lab indicated that 214 experimental rat models fed with diets containing ball moss extracts showed a significant 215 reduction in fasting blood glucose (P < 0.05), fructosamine levels (P<0.05), serum CRP and 216 insulin levels as compared to the control mice. These preliminary findings imply that 217
Tillandsia recurvata may prove effective in improving diabetic indices and could pave the 218 way for novel therapeutic and pharmaceutical interventions for treatment and management 219 of type II diabetes. 220 221
Phytochemistry
223
A number of phytyochemicals present in the ball moss plant have already been identified 224 and characterized ( Figure 2) . Some of the identified compounds have been linked to some of 225 the observed bioactivity of the plant (Table 2) . While our research group isolated compound 226 5 (cycloartane diol), previously isolated compound 8 (cycloartane triol) was also investigated 227 by our group and was shown to be bioactive against our screens as seen in table 2. Due to 228 the increased understanding of adverse drug interactions, modern medicine is inclined to 229
identifying key phytochemicals that are effective in treating chronic ailments as opposed to 230 plant extracts. As previously mentioned, monitoring drug interactions is more feasible when 231
a key constituent is administered rather than many. Even though there is the theory that 232 plant extracts could be more effective biologically speaking due to the synergistic effect 233
amongst their phytochemicals, one begs to argue whether the benefit outweighs the possible 234 risks if any. Given that it is an expensive and time consuming exercise to identify all 235 bioactive metabolites in a plant, scientists have resulted to screening plants with potential 236 medicinal application for safety as well as standardizing crude extracts on the basis of 237 identified chemical markers. Figure 2 
CONCLUSION
292
This paper has summarized available information on the ethnomedicine, pharmacology and 293 phytochemistry properties of Ball Moss, some of which have led to the alpha prostate 294
formula which now is used to enhance prostate health. Given the identified folklore usage 295
and promising pharmacological and phytochemistry potential of this plant, there remains 296 much work to be done. Future research is thus recommended in the following areas: 297 ethnomedical surveys to document hitherto unrecorded folk uses, screening other in vitro 298
and in vivo assays for efficacy and safety as well as phytochemical analysis to isolate 299 bioactive or marker compounds. A combination of chromatographic techniques as well as 300 metabolomics analysis will be useful in future phytochemical analysis. 301 302 303 ACKNOWLEDGEMENTS 304 305
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